Trevor Hallam, Chief Scientific Officer at SUTRO BIOPHARMA, INC. (STRO), sold 2,393 shares at $17.01 ($41K) on 2020-11-27, disclosed to the SEC on 2020-11-30.
Scheduled sale ($41k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| STRO | SELL | 2020-11-06 | $251K | — | Filing → |
| STRO | SELL | 2020-09-28 | $10K | — | Filing → |
| STRO | SELL | 2020-08-27 | $9K | — | Filing → |